FDA Clarifies ANDA Active Ingredient Sameness Evaluation In Draft Guidance | MoFo Life Sciences
On November 8, 2022, FDA issued a draft guidance document on Sameness Evaluations in an ANDA — Active Ingredients (“Draft Guidance”). In the Draft Guidance, FDA indicated that the...
Source: jdsupra.com